risedronic acid has been researched along with Cerebral Palsy, Athetoid in 3 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohran, V | 1 |
| Cassedy, A | 1 |
| Hawkins, A | 1 |
| Bean, J | 1 |
| Heubi, J | 1 |
| Iwasaki, T | 2 |
| Takei, K | 1 |
| Nakamura, S | 1 |
| Hosoda, N | 1 |
| Yokota, Y | 1 |
| Ishii, M | 2 |
| Nonoda, Y | 1 |
3 trials available for risedronic acid and Cerebral Palsy, Athetoid
| Article | Year |
|---|---|
Oral risedronate sodium improves bone mineral density in non-ambulatory patients: a randomized, double-blind, placebo controlled trial.
Topics: Absorptiometry, Photon; Adolescent; Adult; Alkaline Phosphatase; Biomarkers; Bone Density; Bone Dens | 2013 |
Secondary osteoporosis in long-term bedridden patients with cerebral palsy.
Topics: Absorptiometry, Photon; Adolescent; Alkaline Phosphatase; Anticonvulsants; Benzodiazepines; Biomarke | 2008 |
Long-term outcomes of children and adolescents who had cerebral palsy with secondary osteoporosis.
Topics: Adolescent; Alkaline Phosphatase; Bone Density; Bone Density Conservation Agents; Cerebral Palsy; Ch | 2012 |